Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways.
Yanghao ChenWante LinLingfeng ZhongZimin FangBozhi YeZhe WangNipon ChattipakornWeijian HuangGuang LiangGaojun WuPublished in: Cardiovascular drugs and therapy (2022)
Our results showed that bicyclol has potential as a drug to treat obesity-induced cardiomyopathy.
Keyphrases